Immunosuppression induction with rabbit antithymocyte globulin in heart transplantation patients: 6-year experience at the Sheba Medical Center

Transplant Proc. 2000 Jun;32(4):737-9. doi: 10.1016/s0041-1345(00)00963-5.

Authors

J Lavee¹, D Bar-Zohar, Y Har-Zahav, D Freimark, Y Casif, A Shinfeld, A K Smolinsky

Affiliation

¹ Heart Transplantation Unit, Department of Cardiac Surgery, and the Heart Institute, Chaim Sheba Medical Center, Tel-Hashomer, Israel.

PMID: 10856565
DOI: 10.1016/s0041-1345(00)00963-5

No abstract available

MeSH terms

Adolescent
Adult
Aged
Animals
Antilymphocyte Serum / therapeutic use*
Azathioprine / therapeutic use
Child
Child, Preschool
Cyclosporine / therapeutic use
Drug Therapy, Combination
Female
Graft Rejection / epidemiology
Heart Transplantation / immunology*
Heart Transplantation / mortality
Humans
Immunosuppressive Agents / therapeutic use*
Israel
Lymphocyte Count
Male
Methylprednisolone / therapeutic use
Middle Aged
Prednisone / therapeutic use
Rabbits
Retrospective Studies
Survival Rate

Substances

Antilymphocyte Serum
Immunosuppressive Agents
Cyclosporine
Azathioprine
Prednisone
Methylprednisolone